
CAS 222716-34-9
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 Produkte.
3-(Benzo[D]Thiazol-2-Yl)-6-Ethyl-7-Hydroxy-8-(Piperidin-1-Ylmethyl)-4H-Chromen-4-One
CAS:3-(Benzo[D]Thiazol-2-Yl)-6-Ethyl-7-Hydroxy-8-(Piperidin-1-Ylmethyl)-4H-Chromen-4-OneReinheit:99%Molekulargewicht:420.52g/molSZL P1-41
CAS:SZL P1-41 inhibits Skp2, blocks complex formation, and halts ubiquitination, promoting cell senescence, reducing glycolysis, and exhibiting antitumor effects.Formel:C24H24N2O3SReinheit:99.60% - 99.87%Farbe und Form:SolidMolekulargewicht:420.523-(2-Benzothiazolyl)-6-ethyl-7-hydroxy-8-(1-piperidinylmethyl)-4H-1-benzopyran-4-one
CAS:Kontrolliertes Produkt<p>Stability Hygroscopic<br>Applications 3-(2-Benzothiazolyl)-6-ethyl-7-hydroxy-8-(1-piperidinylmethyl)-4H-1-benzopyran-4-one is involved in the pharmacological inactivation of Skp2 E3 ligase.<br>References Chan, C., et al.: Cell, 154, 556-568 (2013)<br></p>Formel:C24H24N2O3SFarbe und Form:NeatMolekulargewicht:420.52SZL P1-41
CAS:<p>SZL P1-41 is a secretase inhibitor that inhibits the activity of ubiquitin ligases. It has been shown to inhibit the progress of Alzheimer's disease in wild-type mice, and it also inhibits cell growth and proliferation in prostate cancer cells. SZL P1-41 inhibits the fibrillization of amyloid protein by preventing its binding to other proteins, which decreases the production of beta-amyloid peptides. This drug is currently being investigated as a potential anticancer agent due to its ability to inhibit cell cycle progression and induce apoptosis.</p>Formel:C24H24N2O3SReinheit:Min. 95%Molekulargewicht:420.52 g/mol




